Why is RECHALLENGE so dangerous for the experimental genetic injections? Part 2
RECHALLENGE is the cause of many serious adverse reactions for the experimental genetic injections
In Part 1, I explained how causality is assigned. If you were perfectly fine before you received the experimental genetic injections, and you became ill or extremely ill immediately after the administration of the experimental injection, the causality is at least POSSIBLY RELATED. The temporal relationship to the administration of the experimental genetic injection, is sufficient to make this determination. Perhaps a mathematical whizz who reads this Substack, can calculate the probability of the SERIOUS ADVERSE EVENT occurring purely by chance, immediately after the injection.
Under normal circumstances an examination of your medical notes and medical history, may allow the probability to be increased to PROBABLY RELATED. A successful DECHALLENGE is not feasible because of the nature of the injections. However, a causality assignment of DEFINITELY RELATED is not feasible, because it is not possible to turn off the production of the Spike Protein in the body, i.e. DECHALLENGE and then RECHALLENGE. However, if you experience the same serious adverse outcomes every time you take one of the Booster injections, this is supportive of a PROBABLY RELATED causality assignment.
In Part 1, I wrote about the process of RECHALLENGE, and how it can be useful to assign causality. It is important that we understand the risks of RECHALLENGE with these injections because RECHALLENGE occurs each time the injection is administered. This has been conveniently called Boosting.
Dangers of RECHALLENGE with the experimental genetic injections
When the experimental genetic injections were rolled out, everyone was told to expect to feel unwell after the administration of the injections. They were even offered time off work to recover from the adverse effects of the injections.
It was not unusual to hear people discussing their experiences with the injections, and saying words to the effect of, “I feel so bad, but that means it is working.”
What does RECHALLENGE and DECHALLENGE have to do with this?
When adverse outcomes were being experienced after the first injection, this was the body’s immune system reacting to, and fighting the foreign substance that had been injected into it.
After the injection, the formulation is transported and taken up by the cells throughout the body. The messenger RNA takes over the machinery of the cell, telling it to produce Spike Protein. There is no way to turn off the cellular manufacturing process that results. The Spike Protein is being produced in cells throughout the body. For many people, even their first injection, was traumatic enough; they could not take another injection, because it would have killed them.
www.realnotrare.com provides lots of stories of real life adverse experiences with the injections. Many of the injured explain that their lives were changed after the first reaction, and not for the better. On the website, www.realnotrare.com Mr. Ernesto Ramirez describes what happened to his son Ernest Jr., who died 5 days after the Pfizer injection.
https://www.realnotrare.com/post/ernest-ramirez
Please visit the above page and watch the videos. It is vital that Mr. Ramirez’ story is told so that other parents can understand that there are very real risks.
Although many people had a bad experience after the first injection, their physicians typically told them to go ahead and take the second scheduled injection. They were RECHALLENGED. Why is this so dangerous?
Their bodies had built up immunological defenses to the first injection. The immune system created a mechanism for fighting any reappearance of the substances that were considered dangerous. This defense involves a mechanism of remembering (memory) the previous assault. Upon RECHALLENGE the immune system goes into overdrive, which results in an immunological storm. In some people, death or serious damage to many organs resulted.
When the immune system is very healthy, there appears to be a tendency for it to progressively react more aggressively upon each RECHALLENGE. This tendency for the immune system to over-react was observed with TGN1412, when it was studied in healthy volunteers [2]. All research subjects, who were administered the investigational biological agent, were seriously injured. One of the hypotheses was that the serious adverse reactions were caused by the over reaction of the healthy immune systems of the male subjects [2].
Some people who suffered traumatic experiences describe that they were injured after the second injection with the experimental genetic injection, i.e. the RECHALLENGE. However, for many, there were indications of an adverse reaction after the first injection. This was their body warning them not to take another dose of the injection.
What about Boosters?
Many have had a troubling reaction with the second injection, but it was reasonably well tolerated; the RECHALLENGE will occur when they receive the third or Booster injection. The fourth and fifth injections are likely to lead to increased risk of serious or traumatic injuries for others who have been fine up to that point.
The situation is further complicated because of the variability in the batches that were manufactured. www.howbadismybatch.info provides strong evidence that the batch administered determines the outcome, because of the variability of the quality of the batches.
Advisory — Seriously Consider
If you had a serious adverse reaction after the first injection, do not take a second injection.
If you had a serious adverse reaction after the second injection, do not take a third injection.
If you had a serious adverse reaction after the third injection, do not take a fourth injection.
If you had a serious adverse reaction after the fourth injection, do not take a fifth injection.
… and so on - goodness knows how many Boosters there will be.
Feel free to leave any questions and comments below. I’ll answer as many of the questions as I can.
References
The Safety Assessment of Medicines: Pre and Post-marketing. LH. Speid. Ph.D. Thesis, University of Wales, Department of Clinical Pharmacy, May 1991. The British Library.
“Lessons Learned From the TeGenero First-in-Man Phase 1 Clinical Trial Part 2: Implications for Future First-in-Man Phase 1 Studies,” Speid L. Regulatory Focus, May 2008 .
As always, you are encouraged to seek medical advice for your own personal situation. Whatever you read here, should not take the place of your own personal consultation with your qualified and competent medical advisors.
Work copyrighted and owned by Speid & Associates, Inc.
Thanks so much. I will be sharing Part 1 and Part 2 in my Substack Friday.
Thank you for putting this information in a concise well written summary.